Metavesco's Regulation A Offering Reaches 99% Subscription, Highlighting OTC Market Challenges

Metavesco, Inc. announced that its Regulation A offering is approximately 99% subscribed. The offering was qualified in July at an offering price of $0.0008 per share, reflecting the company's closing market price on the qualification date. As of the announcement, the company's common stock was trading at approximately double the original offering price, representing an uncommon outcome for an OTC-listed issuer that did not price its offering at a discount to market.

Over recent weeks, the company received subscription interest from both existing and new shareholders, including several larger retail investors. Subscriptions reflect continued investor engagement with the company's strategy and communications. Ryan Schadel, CEO of Metavesco, stated that raising capital on the OTC without discounting shares is extremely difficult. He noted that most OTC offerings require significant discounts, lack transparency, or fail to reach completion, a reality that has existed for a long time.

Schadel added that OTC issuers operate under many of the same regulatory obligations as listed companies but without the same infrastructure to engage investors, communicate consistently, or build long-term participation. He stated that this structural imbalance directly impacts liquidity, price discovery, and cost of capital. The company believes that completing its Regulation A offering positions Metavesco with increased financial flexibility to execute on its operating and platform initiatives. Access to growth capital allows the company to invest deliberately in product development, infrastructure, and strategic opportunities. Management believes this strengthened capital position improves execution certainty and alignment with long-term shareholders.

Schadel continued that the outcome was the result of process, noting that while the chosen path is not always easy, the result is clear and the quickly raised capital will help fuel future growth. He emphasized that clear communication, consistent engagement, and treating shareholders as long-term co-owners can materially improve how capital formation works in the OTC. The company views this experience as a case study that informed the development of OTCfi ACCESS, a platform designed to provide OTC issuers with tools to communicate more effectively with shareholders, understand investor engagement, and build durable shareholder bases over time.

Schadel stated that MVCO is the case study that proves out the premier platform of the OTCfi ecosystem and illustrates how issuer-focused infrastructure can improve outcomes in the OTC. He noted the process is repeatable, but most OTC companies lack the infrastructure to support it, and OTCfi ACCESS is being built to address that gap. The company emphasized that market outcomes are not guaranteed and that results depend on a range of factors, including market conditions and issuer-specific execution. This update was initially discussed during a live event and can be replayed at https://x.com/i/spaces. More information about potential factors that could affect the business and financial results is included in the company's filings on https://www.otcmarkets.com.